NCT04265456View on ClinicalTrials.gov

A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

June 15, 2020

Study Completion Date

July 22, 2020

Conditions
Postoperative Pain
Interventions
DRUG

Pregabalin 100mg

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma aminobutyric acid with anticonvulsant, anxiolytic and sleep-modulating properties.

DRUG

Acetaminophen 1300mg

Acetaminophen is a non-salicylate antipyretic and non-opioid analgesic agent.

Trial Locations (1)

91105

Lotus Clinical Resarch,LLC, Pasadena

Sponsors

Lead Sponsor

Nevakar, Inc.
All Listed Sponsors
lead

Nevakar, Inc.

INDUSTRY

NCT04265456 - A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers | Biotech Hunter | Biotech Hunter